Eqis Capital Management Inc. reduced its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC – Get Rating) by 6.8% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,792 shares of the company’s stock after selling 203 shares during the quarter. Eqis Capital Management Inc.’s holdings in Henry Schein were worth $214,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently made changes to their positions in the business. State of Michigan Retirement System boosted its stake in shares of Henry Schein by 0.3% during the 1st quarter. State of Michigan Retirement System now owns 38,360 shares of the company’s stock worth $3,345,000 after acquiring an additional 121 shares during the period. Cambridge Investment Research Advisors Inc. boosted its stake in shares of Henry Schein by 2.4% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 5,262 shares of the company’s stock worth $459,000 after acquiring an additional 122 shares during the period. Stephens Inc. AR boosted its stake in shares of Henry Schein by 5.6% during the 1st quarter. Stephens Inc. AR now owns 2,355 shares of the company’s stock worth $205,000 after acquiring an additional 125 shares during the period. CIBC Asset Management Inc boosted its stake in shares of Henry Schein by 1.0% during the 1st quarter. CIBC Asset Management Inc now owns 13,079 shares of the company’s stock worth $1,140,000 after acquiring an additional 133 shares during the period. Finally, Wetherby Asset Management Inc. boosted its stake in shares of Henry Schein by 1.6% during the 1st quarter. Wetherby Asset Management Inc. now owns 10,860 shares of the company’s stock worth $947,000 after acquiring an additional 171 shares during the period. 94.99% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
HSIC has been the subject of several research reports. Evercore ISI dropped their price target on Henry Schein to $83.00 in a report on Tuesday, August 9th. UBS Group raised Henry Schein from a “sell” rating to a “neutral” rating and set a $80.00 price target for the company in a report on Monday, August 8th. Credit Suisse Group dropped their price target on Henry Schein from $100.00 to $90.00 and set an “outperform” rating for the company in a report on Wednesday, August 3rd. StockNews.com initiated coverage on Henry Schein in a report on Wednesday, October 12th. They set a “buy” rating for the company. Finally, The Goldman Sachs Group cut Henry Schein from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $93.00 to $85.00 in a report on Thursday, July 21st. One investment analyst has rated the stock with a sell rating, four have given a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $84.67.
Henry Schein Price Performance
Henry Schein declared that its Board of Directors has authorized a stock buyback plan on Thursday, August 18th that authorizes the company to repurchase $400.00 million in shares. This repurchase authorization authorizes the company to repurchase up to 4% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company’s board of directors believes its shares are undervalued.
Henry Schein Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
- Get a free copy of the StockNews.com research report on Henry Schein (HSIC)
- Power Integrations Stock Can Power Your Portfolio
- Don’t Chase Walmart Higher, Wait For Extra Low Prices
- Home Depot Results (and Institutions) Are A Catalyst For Lowe’s?
- Agilent Remains In Buy Range Ahead Of Next Week’s Q4 Report
- Three Penny Stocks Making Big Moves In November
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.